🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David R. Wise

NYU Langone Health

ORCID: 0000-0003-3419-4723

Also affiliated with NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing”.

Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106821
N/A
0.673DataRank · unranked
13 citations

Heather H. Cheng, Amy Leader, Laura Gross, Tatiana Sanchez Nolasco, Nataliya Byrne +21 more

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00798-z
N/A
0.345DataRank · unranked
9 citations

Russell K. Pachynski, Samuel R. Denmeade, Rahul Aggarwal, Jiehui Deng, Victor Adorno Febles +27 more

A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0196
N/A
0.274DataRank · unranked
4 citations

Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, Luiza Doro Pereira, Joseph Puccini +13 more

Thrombo-inflammation linking androgen suppression with cardiovascular risk in patients with prostate cancer

Cardio-Oncology(2024)10.1186/s40959-024-00278-2
N/A
0DataRank · unranked
2 citations

David R. Wise, Jeffrey S. Berger, Antonia Beitzen‐Heineke

Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System

European Urology(2020)10.1016/j.eururo.2020.02.004
N/A
0DataRank · unranked
21 citations

Nataliya Byrne, Binhuan Wang, Danil V. Makarov, Daniel Becker, David R. Wise +3 more

2465P Influence of GnRH agonist and GnRH antagonist initiation on platelet activity in patients with prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.08.3080
N/A
0DataRank · unranked
0 citations

Minas P. Economides, Deepak L. Bhatt, Kathryn Hafertepe, Matthew Siskin, David R. Wise +2 more

Immunosuppressive milieu of high-risk localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.344
N/A
0DataRank · unranked
0 citations

Dennis O. Adeegbe, Aarif Ahsan, Jiansheng Wu, Alireza Khodadad-Jamayran, Herbert Lepor +13 more

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac035
N/A
0DataRank · unranked
11 citations

Vaibhav G. Patel, Xiaobo Zhong, Luis A. Pina, Jessica E. Hawley, Emily Lin +17 more